Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14 SEK | -3.45% | -6.35% | -13.58% |
Feb. 29 | Transcript : Physitrack PLC, Q4 2023 Earnings Call, Feb 29, 2024 | |
Feb. 28 | Physitrack PLC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 92.49 | 34.96 | 23.66 | 19.51 | - | - |
Enterprise Value (EV) 1 | 92.49 | 35.21 | 23.66 | 21.61 | 19.51 | 19.51 |
P/E ratio | -94.8 x | 215 x | - | - | - | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 10.9 x | 2.79 x | 1.56 x | 1.11 x | 0.9 x | 0.73 x |
EV / Revenue | 10.9 x | 2.81 x | 1.56 x | 1.23 x | 0.9 x | 0.73 x |
EV / EBITDA | - | 10.2 x | 6.06 x | 4.24 x | 2.64 x | 2.1 x |
EV / FCF | - | -3,543,623 x | - | - | - | - |
FCF Yield | - | -0% | - | - | - | - |
Price to Book | - | 1.56 x | - | - | - | - |
Nbr of stocks (in thousands) | 16,261 | 16,261 | 16,261 | 16,261 | - | - |
Reference price 2 | 5.688 | 2.150 | 1.455 | 1.200 | 1.200 | 1.200 |
Announcement Date | 2/24/22 | 2/28/23 | 2/28/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 8.465 | 12.51 | 15.18 | 17.6 | 21.7 | 26.6 |
EBITDA 1 | - | - | 3.446 | 3.907 | 5.1 | 7.4 | 9.3 |
EBIT 1 | - | - | 1.013 | 0.2865 | 1.3 | 3.5 | 4.5 |
Operating Margin | - | - | 8.09% | 1.89% | 7.39% | 16.13% | 16.92% |
Earnings before Tax (EBT) | - | - | 0.0511 | - | - | - | - |
Net income | 0.6884 | - | 0.0923 | - | - | - | - |
Net margin | - | - | 0.74% | - | - | - | - |
EPS | 0.0700 | -0.0600 | 0.0100 | - | - | - | - |
Free Cash Flow | - | - | -9.936 | - | - | - | - |
FCF margin | - | - | -79.42% | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 6/8/21 | 2/24/22 | 2/28/23 | 2/28/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 2.577 | 3.365 | 3.517 | 3.735 | 3.751 | 3.851 | 3.84 | 4.1 | 4.3 | 4.6 | 4.6 |
EBITDA 1 | 0.7498 | 0.917 | 0.8765 | 0.9221 | 0.9537 | 1.051 | 0.98 | 1.1 | 1.2 | 1.4 | 1.4 |
EBIT 1 | 0.426 | 0.2054 | 0.0601 | 0.1138 | 0.0529 | 0.1265 | -0.0067 | 0.2 | 0.3 | 0.4 | 0.5 |
Operating Margin | 16.53% | 6.1% | 1.71% | 3.05% | 1.41% | 3.29% | -0.17% | 4.88% | 6.98% | 8.7% | 10.87% |
Earnings before Tax (EBT) | -0.0764 | -0.0143 | 0.4682 | -0.153 | - | - | - | - | - | - | - |
Net income | -0.1457 | 0.0167 | 0.6424 | -0.0656 | -0.2517 | -0.2402 | - | - | - | - | - |
Net margin | -5.66% | 0.5% | 18.26% | -1.76% | -6.71% | -6.24% | - | - | - | - | - |
EPS | -0.0100 | - | 0.0300 | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 5/25/22 | 11/7/22 | 2/28/23 | 5/2/23 | 8/15/23 | 11/14/23 | 2/28/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | 0.25 | - | 2.1 | - | - |
Net Cash position 1 | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 0.0737 x | - | 0.4118 x | - | - |
Free Cash Flow | - | - | -9.94 | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | 4.36% | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | 2.71% | - | - | - | - |
Assets | - | - | 3.412 | - | - | - | - |
Book Value Per Share | - | - | 1.380 | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | 4.5 | - | - | - | - |
Capex / Sales | - | - | 35.94% | - | - | - | - |
Announcement Date | 6/8/21 | 2/24/22 | 2/28/23 | 2/28/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-13.58% | 21.49M | |
+14.10% | 81.84B | |
-30.15% | 70.69B | |
+9.37% | 29.03B | |
-11.90% | 16.97B | |
-0.36% | 16.83B | |
-1.12% | 15.28B | |
+5.90% | 12.41B | |
+35.78% | 12.26B | |
-4.20% | 11.86B |
- Stock Market
- Equities
- PTRK Stock
- Financials Physitrack PLC